Vaccine

Established Impact

Editorial Perspective & Metric Analysis

Based on current metadata, Vaccine maintains a competitive position in the GB academic market. With an impact factor of 2.77, it remains a steady venue for researchers in its specific sub-fields.

ISSN (Print) 0264-410X
ISSN (Online) 1873-2518
Publisher Elsevier BV
Country United Kingdom
APC / Cost Inquire with Publisher
Links
Frequently Asked Questions about Vaccine

The current impact factor of Vaccine is 2.770.

No, Vaccine is not an open access journal.

Vaccine is published by Elsevier BV.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Impact Factor
2.770
Current Impact Factor
Historical Trend
Initial data points only
Impact Factors by Year
Year Value Source
2025 2.770 Journal Citation Reports (Clarivate)
Metadata

Last updated: Apr 19, 2026

Updated by: system

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now